BioPharma APAC

CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

In addition to shortening the vaccination cycle by leveraging the advantages of its single-dose regimen, Convidecia™ can be stably transported and st...

May 20, 2022 | News

ASEAN to build its own CDC to mitigate another pandemic risk

Indonesian Health Minister Budi Gunadi Sadikin said that Southeast Asia's regional bloc agreed to solidify the three main pillars of pa...

May 18, 2022 | News

A novel universal antiviral drug introduced in Korea

The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...

May 13, 2022 | News

Clinical Trial Approval For ReCOV In The PRC And The Overseas Clinical Trial Progress Of ReCOV

As disclosed in the prospectus of the Company dated March 21, 2022, the Group had initiated subject enrollment for the phase II/III clinical trial for...

May 06, 2022 | News

Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama

Dr. Sina Bavari, co-founder of Healion Bio, noted "Highly contagious pathogens can rarely be stopped by testing, vaccines, and hospital therapeutics alone....

April 30, 2022 | News

Chiropractors, Researchers Begin the Hunt for Long COVID Therapy

Leading clinical chiropractic physicians, including those who have experienced in managing WFH pain for COVID-19, are collecting early data with researcher...

April 25, 2022 | News

Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine

Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 Immune response confirmed in...

April 22, 2022 | News

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

April 20, 2022 | News

Novavax and SII Receive EUA for Novavax' COVID-19 Vaccine in Thailand

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectiou...

April 11, 2022 | News

New very-high-sensitivity rapid antigen test kits hit Australian market

Medriva; https://medriva.com, a leading global manufacturer of COVID-19 testing and vaccination products, announced the Australian availability ...

April 08, 2022 | News

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...

April 07, 2022 | News

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...

April 05, 2022 | News

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

Pre-clinical trial results showed that CanSinoBIO's COVID-19 mRNA vaccine can induce high-titer neutralizing antibody levels against multiple SARS-CoV-2 va...

April 04, 2022 | News

Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the EU to Adolescents (Ages 12-17)

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

April 01, 2022 | News

Stay Connected